Comprehensive Longevity
Testing Protocol
A comprehensive new-client assessment battery covering body composition, cardiovascular fitness, musculoskeletal strength, neuromotor function, metabolic health, and cognitive baseline. Every test includes evidence-backed scoring rubrics stratified by sex and decade of life.
Protocol Index
Body Composition & Anthropometrics
Body composition is a foundational longevity marker. Visceral adiposity is independently predictive of cardiovascular disease, metabolic syndrome, and all-cause mortality. Lean mass preservation is the single strongest hedge against sarcopenia and frailty.
The Visbody scanner provides a non-invasive, radiation-free body composition estimate with 3D postural analysis. While not as precise as DEXA for body fat quantification, it delivers circumference measurements, body fat percentage estimates, posture deviation analysis, and segmental body shape data — all within 60 seconds. Peter Attia emphasizes in Outlive that body composition — not BMI — is what matters. Excess visceral fat drives insulin resistance, systemic inflammation, and dramatically increases cardiovascular and cancer risk. Tracking body composition over time reveals whether a person is losing lean mass (the hallmark of aging) or gaining metabolically dangerous visceral fat.
- Client removes all outer clothing; wears form-fitting underwear or provided scan shorts only. Remove jewelry, watches, hair ties.
- Client stands barefoot on the scanner platform in a neutral anatomical position: arms slightly abducted (~15°), feet shoulder-width on marked positions, eyes forward.
- Scanner performs a 35-second 360° infrared scan. Client remains motionless.
- System generates: body fat % estimate, lean mass estimate, waist/hip/chest/thigh circumferences, waist-to-hip ratio, posture deviation report, and 3D avatar.
- Record all metrics in client profile. Flag posture deviations for mobility assessment.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | 8–13% | 14–17% | 18–22% | 23–27% | 28%+ |
| 30–39 | 10–15% | 16–19% | 20–24% | 25–28% | 29%+ |
| 40–49 | 12–17% | 18–21% | 22–25% | 26–29% | 30%+ |
| 50–59 | 14–19% | 20–23% | 24–27% | 28–31% | 32%+ |
| 60–69 | 16–21% | 22–25% | 26–29% | 30–33% | 34%+ |
| ▸ FEMALE | |||||
| 18–29 | 16–21% | 22–25% | 26–29% | 30–34% | 35%+ |
| 30–39 | 17–22% | 23–26% | 27–31% | 32–35% | 36%+ |
| 40–49 | 19–24% | 25–28% | 29–33% | 34–37% | 38%+ |
| 50–59 | 21–26% | 27–31% | 32–35% | 36–39% | 40%+ |
| 60–69 | 22–28% | 29–33% | 34–37% | 38–41% | 42%+ |
Cardiovascular Fitness
VO₂ max is the single strongest predictor of all-cause mortality — stronger than smoking, hypertension, or diabetes as a risk factor. Peter Attia calls it "the most powerful longevity biomarker we have." Moving from the bottom 25th percentile to above the 75th percentile is associated with a 5x reduction in mortality risk.
VO₂ max measures the maximum volume of oxygen your body can utilize during intense exercise — the gold standard of cardiorespiratory fitness. A 2018 JAMA study by Mandsager et al. analyzing 122,007 patients found that low cardiorespiratory fitness was a stronger predictor of mortality than smoking, diabetes, or coronary artery disease. Moving from the lowest fitness quintile to just above average was associated with a 50% reduction in mortality. Peter Attia recommends all patients target at minimum the 75th percentile for their age/sex, with an aspirational goal of the 90th+ percentile — which functionally "makes you a decade younger." The American Heart Association published a 2016 scientific statement recommending VO₂ max be assessed as a clinical vital sign.
- Client fasts for 2+ hours prior. No caffeine for 4 hours. No intense exercise in the prior 24 hours.
- Fit metabolic cart mask (gas analyzer). Calibrate O₂ and CO₂ sensors. Apply heart rate chest strap.
- Graded treadmill protocol (modified Bruce protocol): Begin at 2.7 km/h, 0% grade. Increase speed and/or incline every 3 minutes.
- Client exercises to volitional exhaustion. Technician monitors for VO₂ plateau (increase <150 mL/min despite increasing workload), RER ≥ 1.10, and HR within 10 bpm of age-predicted max.
- Record peak VO₂ (mL/kg/min), max HR, RER, time to exhaustion, ventilatory thresholds (VT1 and VT2).
- 5-minute active cooldown. Monitor HR recovery at 1 min and 2 min post-test.
| Age | Superior (90th) | Excellent (75th) | Good (50th) | Fair (25th) | Poor (<25th) |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥55 | 49–54 | 43–48 | 37–42 | <37 |
| 30–39 | ≥52 | 47–51 | 40–46 | 34–39 | <34 |
| 40–49 | ≥50 | 44–49 | 37–43 | 31–36 | <31 |
| 50–59 | ≥45 | 39–44 | 34–38 | 28–33 | <28 |
| 60–69 | ≥41 | 35–40 | 30–34 | 24–29 | <24 |
| ▸ FEMALE | |||||
| 18–29 | ≥49 | 43–48 | 37–42 | 31–36 | <31 |
| 30–39 | ≥45 | 39–44 | 34–38 | 28–33 | <28 |
| 40–49 | ≥42 | 36–41 | 31–35 | 25–30 | <25 |
| 50–59 | ≥38 | 33–37 | 28–32 | 22–27 | <22 |
| 60–69 | ≥34 | 29–33 | 24–28 | 19–23 | <19 |
Heart rate recovery measures how quickly the parasympathetic nervous system re-engages after peak exertion. A slow recovery signals autonomic dysfunction and is an independent predictor of mortality. A landmark study by Cole et al. (NEJM, 1999) found that a decline of ≤12 bpm in the first minute after peak exercise was associated with a 4x increase in mortality risk over 6 years, regardless of workload achieved. This is measured immediately after the VO₂ max test, making it cost-free to include.
- Performed immediately following the VO₂ max test. Client transitions to active cooldown (slow walk, 2.0 km/h, 0% grade).
- Record HR at test cessation (peak HR). Record HR at exactly 60 seconds and 120 seconds post-cessation.
- Calculate HRR-1 = Peak HR − HR at 1 min. Calculate HRR-2 = Peak HR − HR at 2 min.
| Rating | HRR at 1 min (bpm drop) | Clinical Significance |
|---|---|---|
| Excellent | ≥ 40 bpm | Superior parasympathetic tone |
| Good | 30–39 bpm | Strong autonomic function |
| Normal | 18–29 bpm | Adequate recovery |
| Below Average | 13–17 bpm | Reduced vagal reactivation |
| Abnormal | ≤ 12 bpm | 4x elevated mortality risk — further investigation warranted |
Strength & Musculoskeletal
Muscular strength is the most under-appreciated longevity biomarker. Grip strength alone is a stronger predictor of cardiovascular death than systolic blood pressure. Loss of lean mass after 30 accelerates at ~3–8% per decade, and by 80, most people have lost 30–40% of their peak muscle. Peter Attia calls strength training "the most important form of exercise for longevity."
Grip strength is arguably the single most powerful proxy biomarker in the strength domain. A Lancet study (Leong et al., 2015) of 140,000 adults across 17 countries found that every 5 kg decrease in grip strength was associated with a 17% increased risk of cardiovascular death, a 16% increase in all-cause mortality, and a 9% increase in stroke risk. Peter Attia emphasizes that a strong grip reflects stability and strength through the entire upper kinetic chain — forearm, shoulder, scapula, and trunk. As he notes, "there's really no example where a person has a very strong grip but their forearm, deltoids, scapula, triceps are all weak."
- Use a calibrated Jamar hydraulic hand dynamometer (or equivalent). Set handle to position II (standard).
- Client seated, back straight, feet flat. Shoulder adducted, neutrally rotated. Elbow flexed at 90°. Forearm neutral. Wrist 0–15° ulnar deviation. Arm unsupported.
- Instruct: "Squeeze as hard as you can for 3–5 seconds." Provide verbal encouragement.
- Perform 3 trials per hand, alternating hands. Rest 30 seconds between trials. Record best of 3 trials for each hand.
- Record: dominant hand max (kg), non-dominant hand max (kg), and note if difference exceeds 10% (potential asymmetry flag).
| Age | Excellent (90th) | Good (75th) | Average (50th) | Below Avg (25th) | Poor (<10th) |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥56 | 50–55 | 44–49 | 38–43 | <35 |
| 30–39 | ≥55 | 49–54 | 43–48 | 37–42 | <34 |
| 40–49 | ≥52 | 46–51 | 40–45 | 34–39 | <31 |
| 50–59 | ≥48 | 42–47 | 36–41 | 30–35 | <28 |
| 60–69 | ≥44 | 38–43 | 32–37 | 26–31 | <24 |
| ▸ FEMALE | |||||
| 18–29 | ≥38 | 33–37 | 28–32 | 23–27 | <20 |
| 30–39 | ≥37 | 32–36 | 27–31 | 22–26 | <19 |
| 40–49 | ≥35 | 30–34 | 25–29 | 20–24 | <18 |
| 50–59 | ≥31 | 27–30 | 22–26 | 18–21 | <16 |
| 60–69 | ≥28 | 24–27 | 20–23 | 16–19 | <14 |
Peter Attia uses the dead hang as one of his primary functional longevity tests. It integrates grip endurance, shoulder stability, lat engagement, and upper-body muscular endurance into a single assessment. Attia sets the bar at 2 minutes for men and 90 seconds for women at age 40, decreasing slightly per decade thereafter. Beyond being a test, the dead hang is therapeutic — decompressing the spine, improving shoulder mobility, and strengthening the connective tissue of the hands and forearms. As a test, it correlates strongly with the capacity to perform daily tasks requiring upper-body engagement well into old age — carrying groceries, lifting luggage, rising from a chair using armrests.
- Use a standard pull-up bar at sufficient height that feet clear the floor with arms fully extended.
- Client grips bar with overhand (pronated) grip, slightly wider than shoulder width. No gloves or straps.
- Lift feet off floor. Arms fully extended. Slight shoulder engagement (not fully passive/relaxed into sockets). Body straight, no swinging or kipping.
- Start timer when feet leave ground. Stop when any part of body touches ground, grip fails, or client voluntarily releases.
- One attempt. Record time in seconds.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥150s | 120–149s | 80–119s | 40–79s | <40s |
| 30–39 | ≥135s | 110–134s | 70–109s | 35–69s | <35s |
| 40–49 | ≥120s | 90–119s | 60–89s | 30–59s | <30s |
| 50–59 | ≥100s | 75–99s | 45–74s | 20–44s | <20s |
| 60–69 | ≥80s | 60–79s | 30–59s | 15–29s | <15s |
| ▸ FEMALE | |||||
| 18–29 | ≥110s | 90–109s | 55–89s | 25–54s | <25s |
| 30–39 | ≥100s | 80–99s | 45–79s | 20–44s | <20s |
| 40–49 | ≥90s | 70–89s | 40–69s | 15–39s | <15s |
| 50–59 | ≥75s | 55–74s | 30–54s | 10–29s | <10s |
| 60–69 | ≥60s | 40–59s | 20–39s | 8–19s | <8s |
Attia describes the farmer's carry as one of the two best at-home functional strength tests alongside the dead hang. It combines grip strength, core stability, postural control, and total-body muscular endurance under load. The target he sets for a 40-year-old man is to carry total bodyweight (split across both hands) for 90 seconds. For women, 75% of bodyweight. This simulates real-world demands — carrying groceries, luggage, children — that directly predict independence in older age.
- Use hex bar or two equally weighted dumbbells/kettlebells. Total load = client's bodyweight for males, 75% bodyweight for females.
- Client lifts weights from standing position. Walks at a controlled, steady pace on flat, clear 10m corridor (back-and-forth).
- Maintain upright posture — no forward lean, no shrugging. Arms straight at sides.
- Timer starts when client begins walking. Timer stops when weights are dropped, posture collapses, or client voluntarily stops.
- Record: total time in seconds, total distance covered, load carried.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| ▸ MALE (load = bodyweight) | |||||
| 18–29 | ≥120s | 90–119s | 60–89s | 30–59s | <30s |
| 30–39 | ≥110s | 85–109s | 55–84s | 25–54s | <25s |
| 40–49 | ≥90s | 70–89s | 45–69s | 20–44s | <20s |
| 50–59 | ≥75s | 55–74s | 35–54s | 15–34s | <15s |
| 60–69 | ≥60s | 45–59s | 25–44s | 10–24s | <10s |
| ▸ FEMALE (load = 75% bodyweight) | |||||
| 18–29 | ≥110s | 85–109s | 55–84s | 25–54s | <25s |
| 30–39 | ≥100s | 75–99s | 45–74s | 20–44s | <20s |
| 40–49 | ≥90s | 65–89s | 40–64s | 15–39s | <15s |
| 50–59 | ≥75s | 55–74s | 30–54s | 10–29s | <10s |
| 60–69 | ≥60s | 40–59s | 20–39s | 8–19s | <8s |
Attia identifies the wall sit as a reliable test of isometric quadriceps strength when a formal leg extension or leg press is not available. Lower body strength is critical for fall prevention — the leading cause of injury-related death in adults over 65. Quadriceps strength specifically determines ability to rise from a chair, climb stairs, and decelerate during walking. Loss of quad strength is one of the earliest detectable declines in aging and a direct predictor of loss of independence.
- Client stands with back against smooth wall. Feet shoulder-width apart, approximately 2 feet from wall.
- Slide down until thighs are parallel to floor (knees at 90°). Back flat against wall. Arms crossed at chest or hands on hips (not on thighs).
- Timer starts in position. Timer stops when any form break: thighs rise above parallel, hands touch thighs, back leaves wall, or client stands.
- Record time in seconds. One attempt.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥150s | 120–149s | 75–119s | 40–74s | <40s |
| 30–39 | ≥135s | 105–134s | 60–104s | 30–59s | <30s |
| 40–49 | ≥120s | 90–119s | 50–89s | 25–49s | <25s |
| 50–59 | ≥100s | 75–99s | 40–74s | 20–39s | <20s |
| 60–69 | ≥80s | 60–79s | 30–59s | 15–29s | <15s |
| ▸ FEMALE | |||||
| 18–29 | ≥120s | 90–119s | 60–89s | 30–59s | <30s |
| 30–39 | ≥105s | 80–104s | 50–79s | 25–49s | <25s |
| 40–49 | ≥90s | 65–89s | 40–64s | 20–39s | <20s |
| 50–59 | ≥75s | 55–74s | 30–54s | 15–29s | <15s |
| 60–69 | ≥60s | 45–59s | 20–44s | 10–19s | <10s |
Balance & Neuromotor Function
Balance is the canary in the coal mine for aging. It integrates vision, vestibular function, proprioception, and muscular coordination. A 2022 British Journal of Sports Medicine study found that inability to stand on one leg for 10 seconds in adults aged 51–75 was associated with an 84% higher risk of all-cause death over 7 years.
The single-leg stance with eyes open tests the integration of all three balance systems (visual, vestibular, proprioceptive). A 2024 Mayo Clinic study found that one-legged balance — particularly on the non-dominant leg — showed the highest rate of decline with age of any physical measure tested, more than grip strength, knee strength, or gait speed. The inability to hold 10 seconds is associated with significantly elevated mortality risk (Araujo et al., BJSM 2022).
- Client barefoot on flat, hard surface. Hands on hips.
- Lift one foot off ground (client chooses leg). Non-standing foot may rest against standing ankle or calf. Do not hook behind knee.
- Timer starts when foot leaves ground. Timer stops when: standing foot shifts, raised foot touches ground, hands leave hips, or 60 seconds reached.
- Perform 3 trials per leg. Record best of 3 for each leg. Test both dominant and non-dominant.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| 18–29 | 60s (max) | 50–59s | 40–49s | 25–39s | <25s |
| 30–39 | 55–60s | 45–54s | 35–44s | 20–34s | <20s |
| 40–49 | 50–60s | 42–49s | 30–41s | 15–29s | <15s |
| 50–59 | 45–60s | 35–44s | 25–34s | 10–24s | <10s |
| 60–69 | ≥32s | 22–31s | 10–21s | 5–9s | <5s |
Closing the eyes removes visual input and forces the body to rely exclusively on vestibular and proprioceptive systems — dramatically harder and far more sensitive to aging. A 2014 BMJ study found that individuals aged 53 who could not balance on one leg with eyes closed for more than 2 seconds were three times more likely to die over the subsequent 13 years. This test declines rapidly beginning in the late 20s and is often the first detectable deficit in neuromotor aging.
- Same setup as eyes-open test. Hands on hips, barefoot, flat surface.
- Client closes eyes first, then lifts one foot off ground.
- Timer starts when foot leaves ground. Timer stops on any of: foot touches down, eyes open, hands leave hips, standing foot shifts.
- Perform 3 trials per leg. Record best of 3. Test both legs.
| Age | Excellent | Good | Average | Below Avg | Concern |
|---|---|---|---|---|---|
| 18–29 | ≥28s | 20–27s | 12–19s | 6–11s | <6s |
| 30–39 | ≥22s | 15–21s | 10–14s | 5–9s | <5s |
| 40–49 | ≥18s | 13–17s | 8–12s | 4–7s | <4s |
| 50–59 | ≥12s | 8–11s | 5–7s | 3–4s | <3s |
| 60–69 | ≥8s | 5–7s | 3–4s | 2s | <2s |
Flexibility & Mobility
Mobility is the prerequisite for all other physical capacities. Loss of range of motion precedes loss of strength, which precedes loss of function. Attia uses the deep squat as a fundamental screen — if you can't get your hips below your knees, your movement system is compromised.
The ability to achieve a full-depth squat (hips below knees, heels on ground, torso upright) is fundamental to human movement. It requires adequate ankle dorsiflexion, hip flexion/rotation, thoracic extension, and coordinated motor control. Attia frames this as a non-negotiable for longevity — being unable to get on and off the floor independently is one of the strongest predictors of care dependency and mortality. The sit-to-stand and sit-to-rise test (Brito et al., European Journal of Preventive Cardiology, 2012) found that adults who could not sit and rise from the floor without using hands had 5–6x higher mortality.
- Client stands barefoot, feet shoulder-width apart. Raises arms overhead, elbows extended.
- Descends into a full squat: hips below knees, heels remain flat on floor, arms remain overhead, torso as upright as possible.
- Hold bottom position for 3 seconds. Return to standing.
- Score on 0–3 scale: 3 = full depth, heels down, arms overhead, upright torso. 2 = full depth with minor compensations (slight heel rise, forward lean, or arms drift forward). 1 = cannot reach full depth OR major compensations (heels significantly elevated, torso collapses forward). 0 = cannot attempt / falls / pain.
- Note specific limitations: ankle dorsiflexion, hip impingement, thoracic kyphosis, knee valgus.
| Score | Rating | Interpretation |
|---|---|---|
| 3 | Optimal | Full range, no compensations. Adequate mobility for all movement patterns. |
| 2 | Acceptable | Minor limitations. Targeted mobility work recommended. |
| 1 | Limited | Significant restriction. Priority mobility intervention needed before loaded training. |
| 0 | Severely Limited | Cannot perform. Requires assessment for structural limitation, injury history, or pain. |
Posterior chain flexibility (hamstrings, lower back, calves) is a consistent correlate of lower back pain prevalence and functional mobility. Research published in the American Journal of Physiology (Yamamoto et al., 2009) found that trunk flexibility in middle-aged and older adults was associated with arterial stiffness — less flexible individuals had stiffer arteries, independent of other fitness markers. While not a direct mortality predictor, it is a reliable functional screen for musculoskeletal risk.
- Use a standard sit-and-reach box (26 cm at the feet). Client removes shoes.
- Client sits on floor, legs fully extended, feet flat against box. Knees must remain straight (assistant may gently hold knees).
- Hands together, palms down. Slowly reach forward as far as possible along the ruler. No bouncing.
- Hold farthest position for 2 seconds. Measure to nearest 0.5 cm.
- Perform 3 trials. Record the best.
| Age | Excellent | Good | Average | Below Avg | Poor |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥40 | 34–39 | 29–33 | 24–28 | <24 |
| 30–39 | ≥38 | 33–37 | 28–32 | 23–27 | <23 |
| 40–49 | ≥35 | 29–34 | 24–28 | 18–23 | <18 |
| 50–59 | ≥35 | 28–34 | 24–27 | 16–23 | <16 |
| 60–69 | ≥33 | 25–32 | 20–24 | 15–19 | <15 |
| ▸ FEMALE | |||||
| 18–29 | ≥41 | 37–40 | 33–36 | 28–32 | <28 |
| 30–39 | ≥41 | 36–40 | 32–35 | 27–31 | <27 |
| 40–49 | ≥38 | 34–37 | 30–33 | 25–29 | <25 |
| 50–59 | ≥39 | 33–38 | 30–32 | 25–29 | <25 |
| 60–69 | ≥35 | 31–34 | 27–30 | 23–26 | <23 |
Cardiovascular Health Markers
Resting blood pressure and heart rate are the most accessible windows into cardiovascular health. Hypertension is the number one modifiable risk factor for death globally (GBD Study, The Lancet). Every 20/10 mmHg increase above 115/75 doubles cardiovascular disease risk.
Hypertension is the single largest contributor to cardiovascular mortality worldwide. The landmark SPRINT trial (2015) demonstrated that intensive BP control (target <120 systolic) reduced cardiovascular events by 25% and all-cause mortality by 27% compared to standard treatment (<140). Bryan Johnson targets systolic BP in the 110–120 range as part of his Blueprint protocol. Attia emphasizes that blood pressure is one of the few directly actionable, high-leverage longevity interventions.
- Client seated quietly for 5 minutes. Feet flat on floor, back supported, legs uncrossed. Arm resting on table at heart level.
- Use validated automatic oscillometric cuff. Correct cuff size (bladder encircles ≥80% of arm circumference).
- No talking during measurement. Take 3 readings, 1 minute apart. Record the average of readings 2 and 3.
- Measure both arms on first visit. If difference >10 mmHg systolic between arms, use the higher arm for all future readings.
| Category | Systolic (mmHg) | Diastolic (mmHg) | Clinical Action |
|---|---|---|---|
| Optimal | <110 | <70 | No action — ideal longevity range |
| Normal | 110–119 | 70–79 | Maintain with lifestyle |
| Elevated | 120–129 | <80 | Lifestyle modification, retest in 3 months |
| Stage 1 HTN | 130–139 | 80–89 | Lifestyle + consider pharmacotherapy |
| Stage 2 HTN | ≥140 | ≥90 | Medical referral required |
Resting heart rate reflects cardiovascular efficiency and autonomic balance. A meta-analysis by Zhang et al. (CMAJ, 2016) of over 1.2 million participants found that every 10 bpm increase in resting HR was associated with a 9% increase in cardiovascular mortality and a 16% increase in sudden cardiac death. Resting HR >90 bpm is consistently associated with elevated all-cause mortality. Elite aerobic fitness drives resting HR into the low 50s or below.
- Taken during BP measurement rest period. Client seated quietly for 5 minutes.
- Record from validated pulse oximeter or BP cuff readout. Average of 3 readings.
| Category | RHR (bpm) | Interpretation |
|---|---|---|
| Athlete/Excellent | <55 | Superior cardiovascular efficiency |
| Good | 55–64 | Well-conditioned |
| Average | 65–74 | Normal range |
| Below Average | 75–84 | Reduced conditioning |
| Poor/Elevated Risk | ≥85 | Associated with elevated mortality — lifestyle intervention or medical review |
Autonomic & Nervous System
Heart rate variability (HRV) is a non-invasive window into autonomic nervous system function. Low HRV is associated with elevated inflammation, poor stress resilience, cardiovascular disease, and all-cause mortality. It is the most personal of all biomarkers — individual baselines vary enormously.
HRV measures the beat-to-beat variation in heart rhythm, reflecting the dynamic interplay of sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) nervous systems. Higher HRV indicates greater autonomic flexibility — the body's ability to adapt to stress. Andrew Huberman has extensively discussed HRV as a tool for tracking recovery, stress resilience, and overall nervous system health. A 24-hour SDNN below 50ms has been linked to significantly increased all-cause mortality (AHA Scientific Statement, 2022). RMSSD is the most commonly tracked metric via wearables and the most reliable short-term measure of vagal tone.
- Client lies supine in a quiet, dimly lit room. Room temperature 22–24°C. No caffeine in prior 4 hours. No intense exercise in prior 12 hours.
- Apply chest-strap ECG sensor (Polar H10 or equivalent — gold standard over wrist PPG for accuracy).
- Allow 3-minute stabilization period. Then record 5 minutes of continuous R-R interval data.
- Software analysis: calculate RMSSD (primary metric), SDNN, pNN50, and LF/HF ratio.
- Report RMSSD in milliseconds. Compare to age-sex norms and note as baseline for longitudinal tracking.
| Age | High (90th) | Above Avg (75th) | Median (50th) | Below Avg (25th) | Low (10th) |
|---|---|---|---|---|---|
| ▸ MALE | |||||
| 18–29 | ≥80 | 55–79 | 38–54 | 24–37 | <20 |
| 30–39 | ≥65 | 44–64 | 30–43 | 20–29 | <16 |
| 40–49 | ≥55 | 36–54 | 24–35 | 16–23 | <13 |
| 50–59 | ≥45 | 30–44 | 20–29 | 14–19 | <11 |
| 60–69 | ≥38 | 24–37 | 16–23 | 11–15 | <9 |
| ▸ FEMALE | |||||
| 18–29 | ≥85 | 58–84 | 42–57 | 28–41 | <22 |
| 30–39 | ≥70 | 48–69 | 34–47 | 22–33 | <18 |
| 40–49 | ≥55 | 38–54 | 26–37 | 18–25 | <14 |
| 50–59 | ≥45 | 30–44 | 21–29 | 14–20 | <11 |
| 60–69 | ≥38 | 25–37 | 17–24 | 11–16 | <9 |
Respiratory Function
Pulmonary function declines ~1–2% per year after age 25. Reduced lung capacity is independently associated with cardiovascular disease, cognitive decline, and all-cause mortality. A simple breath-hold test provides a low-cost screen for CO₂ tolerance, which reflects respiratory efficiency and autonomic control.
The BOLT score, popularized by Patrick McKeown (author of The Oxygen Advantage) and frequently referenced by Andrew Huberman, measures carbon dioxide tolerance — how efficiently the body handles CO₂. Low BOLT scores (<20s) correlate with chronic over-breathing, mouth breathing, poor sleep quality, exercise-induced asthma, and anxiety. A higher BOLT score indicates better respiratory efficiency, improved oxygen delivery to tissues via the Bohr effect, and greater exercise tolerance. Huberman recommends nasal breathing and CO₂ tolerance training as foundational health practices.
- Client seated comfortably, breathing normally through nose for 2 minutes prior to test.
- After a NORMAL exhale (not forced), client pinches nose and starts timer.
- Timer stops at the FIRST distinct urge to breathe (diaphragmatic contraction, swallowing reflex, or involuntary breath). This is NOT a max breath-hold — it measures CO₂ sensitivity threshold.
- The first breath after the test should be calm and controlled through the nose. If client gasps, the hold was too long — retest after 5 minutes.
- Perform 2 trials with 5-minute rest between. Record the average.
| Score | Rating | Interpretation |
|---|---|---|
| ≥40s | Excellent | Optimal CO₂ tolerance. Efficient breathing pattern. Likely nasal breather. |
| 30–39s | Good | Good respiratory efficiency. Minor room for improvement. |
| 20–29s | Average | Moderate CO₂ tolerance. May benefit from breathing retraining. |
| 10–19s | Below Average | Low tolerance. Likely chronic over-breather. Breathing intervention recommended. |
| <10s | Poor | Dysfunctional breathing pattern. Priority intervention — assess for mouth breathing, sleep-disordered breathing, anxiety-related hyperventilation. |
Cognitive & Reaction Time
Cognitive function and processing speed are often the last things tested — and among the first things that decline. Reaction time is a surprisingly powerful predictor of mortality, independent of fitness level. A study published in PLOS ONE found that slower reaction time increased mortality risk nearly as much as smoking over a 15-year follow-up.
Simple reaction time measures the speed of the entire sensory-motor processing chain: visual perception → neural transmission → motor execution. Hagger-Johnson et al. (PLOS ONE, 2014) studied 5,134 adults and found that slower reaction time was associated with significantly elevated all-cause mortality over 15 years, including cardiovascular and respiratory death — with effect sizes comparable to smoking status. Reaction time declines approximately 1ms per year after age 25, and this decline accelerates after 60. It serves as a non-invasive proxy for overall CNS integrity.
- Use standardized digital reaction time test (computer-based or tablet). Client seated comfortably. Dominant hand on input device (mouse click or screen tap).
- Screen displays a visual stimulus (color change or shape appearance) at random intervals (2–10 seconds).
- Client responds as quickly as possible upon seeing the stimulus.
- Perform 20 trials. Discard fastest and slowest 2 (outlier removal). Record median of remaining 16 trials in milliseconds.
| Age | Excellent | Good | Average | Below Avg | Slow |
|---|---|---|---|---|---|
| 18–29 | <200ms | 200–230ms | 231–270ms | 271–330ms | >330ms |
| 30–39 | <210ms | 210–245ms | 246–285ms | 286–345ms | >345ms |
| 40–49 | <220ms | 220–260ms | 261–305ms | 306–370ms | >370ms |
| 50–59 | <235ms | 235–280ms | 281–330ms | 331–400ms | >400ms |
| 60–69 | <255ms | 255–310ms | 311–370ms | 371–450ms | >450ms |
Assessment Flow & Duration
| # | Test | Duration | Notes |
|---|---|---|---|
| 1 | Intake & Consent | 10 min | Medical history, contraindications screen, informed consent |
| 2 | Visbody 3D Scan | 5 min | Body composition, posture, circumferences |
| 3 | Blood Pressure + RHR | 10 min | 5 min seated rest + 3 readings |
| 4 | HRV (5-min supine) | 10 min | Quiet room, ECG chest strap, 3-min stabilization + 5-min recording |
| 5 | BOLT Score | 5 min | CO₂ tolerance, 2 trials |
| 6 | Visual Reaction Time | 5 min | 20-trial computerized test |
| 7 | Sit-and-Reach | 5 min | Posterior chain flexibility |
| 8 | Deep Squat Assessment | 3 min | Movement quality screen |
| 9 | Single-Leg Balance (EO + EC) | 10 min | Both legs, both conditions, 3 trials each |
| 10 | Grip Strength | 8 min | 3 trials each hand, alternating |
| 11 | Dead Hang | 5 min | Single max-effort attempt |
| 12 | Wall Sit | 5 min | Single max-effort attempt |
| 13 | Farmer's Carry | 8 min | Setup + single attempt at prescribed load |
| 14 | VO₂ Max + HR Recovery | 25 min | Graded treadmill test to exhaustion + cooldown + HRR measurement |
Full protocol repeat: every 90 days for active program participants. Abbreviated retest (VO₂ max, grip, body composition, HRV): every 45 days. Blood pressure and resting HR: every visit or on demand.
WhatsApp us to schedule your 90-minute longevity baseline. Available at both Uluwatu and Canggu locations.